Our data demonstrate a new role of LXR activation in regulating oxidative stress response, which lead to a reduced hyperglycemia and an improved insulin resistance through at least in part the suppression of ROS production and JNK pathway and the activation of Akt. The gene discussed is AKT1; the disease is Insulin resistance.